Skip to content

Kinesio Taping in Subjects With Myofascial Pain Syndrome: a Randomized Controlled Trial

Kinesio Taping on Short Term Changes in Subjects With Myofascial Pain Syndrome: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02029391
Enrollment
31
Registered
2014-01-07
Start date
2013-10-31
Completion date
2013-12-31
Last updated
2014-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial Pain Syndrome

Keywords

Myofascial pain syndrome, taping, manual therapies

Brief summary

Musculoskeletal dysfunction is considered as a major public health problem affecting about one third of the adult population. Myofascial pain syndrome (MPS) characterized by myofacial trigger points as well as fascia tenderness are thought to be the main cause of musculoskeletal dysfunction. The aim of the treatment for musculoskeletal dysfunction is to reduce pain and restore normal function. Clinically, some evidence supports the application of kinesio tape in these patients. The underlying mechanism, however, is not clear. The investigators goal was to validate proposed mechanism of kinesio tape in these patients. The primary outcome are muscle stiffness, pain intensity and sensitivity.

Interventions

Therapist applied non-painful pressure with slowly increase over the myofascial trigger point until he felts a tissue resistance barrier.

OTHERKinesio tape

Kinesio tape was adhered from insertion to origin of the upper trapezius muscle

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* age between 20 and 60 years * shoulder or neck pain corresponding with the area covered by the upper trapezius muscle * Trigger point (taut band) in the upper trapezius muscle

Exclusion criteria

* diagnosis of fibromyalgia syndrome * having undergone myofascial therapy within the past month before the study * history of cervical spine or shoulder surgery * previous history of a whiplash injury; * diagnosis of cervical radiculopathy or myelopathy; * taking medicine that might change the pain intensity or pain threshold, such as analgesics, sedatives, substance abuse (including alcohol, narcotics); * a cognitive impairment that would prevent them from being able to understand and/or participate fully in the intervention or the measures.

Design outcomes

Primary

MeasureTime frame
Muscle stiffnessbaseline, immediate after intervention and at week 1

Secondary

MeasureTime frame
Visual analog scale (VAS)baseline, immediate after intervention and at week 1
Pressure pain thresholdbaseline, immediate after intervention and at week 1

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026